Internal Medicine, Nephrology · Moreno Valley, CA
NPI
1912944653
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
22555 Alessandro Blvd, Suite B
Moreno Valley, CA, 92553
Phone (951) 656-7081
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,031 services
Medicare patients, 2024
250
Average age 68
Drug cost, 2024
$460K
1,155 prescriptions
Company payments, 2025
$570
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yogesh M Patel was code 90960 (esrd related services (not dialysis)), 222 times for 29 patients. In total Yogesh M Patel billed 1,031 services in 22 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 222 | 29 | $280.15 | $62K |
| 99214 Office E&M - Established | Office | 140 | 88 | $57.50 | $8,050 |
| 99232 Hospital E&M - Subsequent | Facility | 135 | 70 | $62.44 | $8,429 |
| 99233 Hospital E&M - Subsequent | Facility | 125 | 57 | $94.25 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 68 | 48 | $12.41 | $844 |
| 90935 Hemodialysis | Facility | 49 | 29 | $56.27 | $2,757 |
| 99222 Hospital E&M - Initial | Facility | 33 | 32 | $100.85 | $3,328 |
| 99215 Office E&M - Established | Office | 19 | 16 | $31.09 | $591 |
| 99213 Office E&M - Established | Office | 19 | 19 | $50.96 | $968 |
| 99204 Office E&M - New | Office | 16 | 16 | $112.40 | $1,798 |
| 99223 Hospital E&M - Initial | Facility | 12 | 11 | $137.85 | $1,654 |
By year: 2022 $203K for 1,443 services; 2023 $131K for 982 services; 2024 $123K for 1,031 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yogesh M Patel prescribed most often to Medicare patients was Prosol (Parenteral Amino Acid 20% No.1), with 77 prescriptions and refills. In total Yogesh M Patel wrote 1,155 Medicare prescriptions that cost $460K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prosol Parenteral Amino Acid 20% No.1 | 77 | 77 | Under 11 | $13K |
| Amlodipine Besylate Generic | 66 | 170 | 22 | $468 |
| Calcium Acetate Generic | 65 | 93 | 17 | $5,961 |
| Losartan Potassium Generic | 65 | 156 | 22 | $475 |
| Nifedipine Er Nifedipine | 63 | 145 | 24 | $2,210 |
| Rayaldee Calcifediol | 63 | 63 | 13 | $76K |
| Farxiga Dapagliflozin Propanediol | 58 | 62 | 12 | $35K |
| Procrit Epoetin Alfa | 51 | 55 | Under 11 | $50K |
| Sevelamer Carbonate Generic | 47 | 54 | Under 11 | $5,095 |
| Xphozah Tenapanor Hcl | 45 | 47 | 15 | $130K |
| Calcitriol Generic | 41 | 100 | 12 | $789 |
| Auryxia Ferric Citrate | 33 | 34 | Under 11 | $62K |
| Furosemide Generic | 32 | 68 | 13 | $149 |
| Carvedilol Generic | 30 | 60 | 14 | $197 |
| Cinacalcet Hcl Generic | 29 | 30 | Under 11 | $5,354 |
Brand drugs: 422 claims; generic drugs: 722 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yogesh M Patel $570 ($570 in general payments such as food, travel and fees) from 11 companies. The largest payer was Travere Therapeutics, Inc. with $113.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 9 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $106 |
| Calliditas Therapeutics US Inc. | 3 | $85.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $75.64 |
| Apellis Pharmaceuticals, Inc. APLS | 3 | $70.06 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31.2 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $20.63 |
| Lilly USA, LLC LLY | 1 | $18.41 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.68 |
| Amgen Inc. AMGN | 1 | $16.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.